comprehensive -WSS

comprehensive

author：leisure time 2025-10-01 21:40:33 - browse：1967

A young boy died in a trial for Pfizer’s experimental gene therapy for Duchenne muscular dystrophy, the company told patient advocates Tuesday.

The boy was enrolled in Daylight, a trial studying the treatment in boys aged 2 or 3. The boy had received the therapy early last year, Pfizer told the advocates in a note posted online by Parent Project Muscular Dystrophy.

Pfizer said the boy died of cardiac arrest, but that it was still working to understand what happened and the exact cause.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the pharma industry — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Supreme Court strikes down use of affirmative action
Next article： What do new weight loss drugs mean for bariatric surgery?

WSS

Psilocybin's anti

Immunocompromised patients offer clues on chronic Covid

The inclusion problem at the heart of rehabilitation research

Departing Stanford president retracts two papers

Microsoft launches AI tool for clinical documentation through Epic

Complete sequence of Y chromosome published for first time

leisure time

comprehensive

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the pharma industry — by subscribing to STAT+.

focus

Medical records are filled with copy

Immunocompromised patients offer clues on chronic Covid

Hollywood unions extend contract negotiations for actors

Head of FDA's diagnostics center, who led through Covid, retires

Moonlake's readout produced a cash windfall. Risks remain

As pharma fights Medicare drug negotiation, hospitals, docs silent

George Santos makes 1st court appearance after pleading not guilty to 13 counts

Mass General, Mayo Clinic look to monetize custom

As demand for Covid shots wanes, Moderna seeks its next success

Medicare explains how it will choose drugs for negotiation

focus

Diversity in medical illustrations gets boost from Chidiebere Ibe

Pumping milk in bathrooms at health conferences is common

Medicare bonuses could stop drug shortages under Senate plan

AstraZeneca bets AAV gene therapy will still deliver the goods

To bolster infectious disease surveillance, genomics powerhouses team up

Appeals court upholds limits to abortion pill

explore

focus

hotspot

Wikipedia